人民财讯10月20日电，润本股份（603193）10月20日发布2025年三季报，公司第三季度营业收入3.42亿 元，同比增长16.67%；净利润7852.28万元，同比下降2.89%。2025年前三季度营业收入12.38亿元，同 比增长19.28%；净利润2.66亿元，同比增长1.98%；基本每股收益0.66元。 ...

申万宏源证券承销保荐有限责任公司 关于润本生物技术股份有限公司 使用部分暂时闲置募集资金进行现金管理的核查意见 申万宏源证券承销保荐有限责任公司（以下简称"申万宏源承销保荐"、"保 荐人"）作为润本生物技术股份有限公司（以下简称"润本股份"、"公司"）持续 督导工作的保荐人，根据《上市公司募集资金监管规则》《上海证券交易所股票 上市规则》《上海证券交易所上市公司自律监管指引第 11 号——持续督导》《上 海证券交易所上市公司自律监管指引第 1 号——规范运作》等相关规定，对润本 股份使用部分暂时闲置募集资金进行现金管理的事项进行了核查，具体情况如下： 一、募集资金基本情况 经中国证券监督管理委员会出具的《关于同意润本生物技术股份有限公司首 次公开发行股票注册的批复》（证监许可[2023]1631 号），公司于 2023 年 9 月 27 日首次公开发行人民币普通股（A 股）60,690,000 股，发行价格为人民币 17.38 元/股，募集资金总额为人民币 1,054,792,200.00 元，扣除不含税的发行费用人民 币 83,563,748.31 元，实际募集资金净额为人民币 971,228,451.69 ...

智通财经APP讯，润本股份(603193.SH)披露2025年第三季度报告，公司前三季度实现营收12.38亿元， 同比增长19.28%;归属于上市公司股东的净利润2.66亿元，同比增长1.98%;扣非净利润2.51亿元，同比下 降1.79%;基本每股收益0.66元。 ...

证券代码：603193 证券简称：润本股份 公告编号 2025-043 润本生物技术股份有限公司 关于 2025 年第三季度主要经营数据的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上海证券交易所上市公司自律监管指引第 3 号行业信息 披露：第十三号——化工》的要求，现将润本生物技术股份有限公司（以下简称 "公司"）2025 年第三季度主要经营数据披露如下： 注：产量包括自产、采购、委托加工数量。产量、销量为最小销售单位，包括支、瓶、盒、 包等。 二、2025 年第三季度公司主要产品和原材料的价格变动情况 （一）主要产品价格变动情况 2025 年第三季度，公司主要产品的价格详见下表： | 主要产品 | 2024 年第三季度 平均售价 | 2025 年第三季度 平均售价 | 同比变动比率 | | --- | --- | --- | --- | | 驱蚊产品系列 | 5.48 | 6.14 | 12.04% | | 婴童护理产品系列 | 7.89 | 8.51 | 7.86% | | 精油产品系列 | ...

证券代码：603193 证券简称：润本股份 公告编号：2025-040 润本生物技术股份有限公司 关于使用部分暂时闲置募集资金 进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●投资种类 经中国证券监督管理委员会出具的《关于同意润本生物技术股份有限公司首 次公开发行股票注册的批复》（证监许可[2023]1631号），公司于2023年9月27日 首次公开发行人民币普通股（A股）60,690,000股，发行价格为人民币17.38元/股， 募集资金总额为人民币1,054,792,200.00元，扣除不含税的发行费用人民币 83,563,748.31元，实际募集资金净额为人民币 971,228,451.69 元，其中增加股本人 民币60,690,000.00元，增加资本公积人民币 910,538,451.69元。社会公众股股东均 以货币出资。 润本生物技术股份有限公司（以下简称"公司"或"润本股份"）拟使用 部分暂时闲置募集资金投资于安全性高、流动性好、风险低的现金管理产品。 ●投资金额 公司拟使用 ...

证券代码：603193 证券简称：润本股份 公告编号： 2025-041 润本生物技术股份有限公司 关于续聘会计师事务所的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责 重要内容提示： ● 润本生物技术股份有限公司拟续聘广东司农会计师事务所（特殊普通合伙） 作为公司 2025 年度的财务审计机构和内控审计机构。 润本生物技术股份有限公司（以下简称"公司"）于2025 年 10 月 20 日召开 第二届董事会第十次会议，审议通过了《关于续聘会计师事务所的议案》，同意续 聘广东司农会计师事务所（特殊普通合伙）（以下简称"司农会计师事务所"）为公司 2025 年度财务报告及内部控制审计机构，该事项尚需提交公司股东会审议通过，现 将有关情况公告如下： 一、拟聘任会计师事务所的基本情况 （一）机构信息 1. 基本信息 会计师事务所名称：广东司农会计师事务所（特殊普通合伙） 成立日期：2020 年 11 月 25 日 组织形式：合伙企业（特殊普通合伙） 注册地址：广州市南沙区南沙街兴沙路 6 号 704 房-2 首席合伙人：吉争雄 截至 ...

证券代码：603193 证券简称：润本股份 公告编号：2025-042 润本生物技术股份有限公司 关于召开2025年第三次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一)股东会类型和届次 2025年第三次临时股东会 (二)股东会召集人：董事会 (三)投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合的方 式 (四)现场会议召开的日期、时间和地点 (七)涉及公开征集股东投票权 无 召开的日期时间：2025 年 11 月 5 日 15 点 30 分 召开地点：广东省广州市天河区珠江新城华夏路 28 号富力盈信大厦 40 楼润 本生物技术股份有限公司会议室 (五)网络投票的系统、起止日期和投票时间。 股东会召开日期：2025年11月5日 本次股东会采用的网络投票系统：上海证券交易所股东会网络投票系统 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2025 年 11 月 5 日 至2025 年 11 月 5 日 采用上海证券交易所网络投 ...

证券代码：603193 证券简称：润本股份 公告编号：2025-044 润本生物技术股份有限公司 第二届董事会第十次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 润本生物技术股份有限公司（以下简称"公司"）第二届董事会第十次会议 于 2025 年 10 月 20 日在公司会议室以现场的方式召开。会议通知已于 2025 年 10 月 14 日通过书面文件、电子邮件的方式送达各位董事。本次会议应出席董事 6 人，实际出席董事 6 人。董事长赵贵钦先生为会议主持人，公司高级管理人员列 席会议。本次会议的召集、召开和表决程序符合《公司法》等有关法律、行政法 规、部门规章、规范性文件和《公司章程》的规定。 二、董事会会议审议情况 经与会董事认真审议，会议形成了如下决议： （一）审议通过《关于<2025 年第三季度报告>的议案》 2025 年前三季度公司实现营业收入 12.38 亿元，同比增长 19.28 %，实现归 属于母公司净利润 2.66 亿元，同比增长 1.98%。 经董事会审议，同意公司使 ...

Core Viewpoint - Runben Co., Ltd. (603193.SH) reported a revenue of 342 million yuan for Q3 2025, reflecting a year-on-year growth of 16.67%, while the net profit attributable to shareholders decreased by 2.89% to 78.52 million yuan [1] Financial Performance - Revenue for Q3 2025 reached 342 million yuan, marking a 16.67% increase compared to the previous year [1] - Net profit attributable to shareholders was 78.52 million yuan, showing a decline of 2.89% year-on-year [1] - The net profit after deducting non-recurring gains and losses was 74.27 million yuan, which represents a year-on-year decrease of 7.58% [1]

Important Disclosures This section provides key statements from the board and management and clarifies the audit status of the financial statements [Board of Directors and Management Statement](index=1&type=section&id=Board%20of%20Directors%20and%20Management%20Statement) Runben Co., Ltd.'s Board of Directors, senior management, and key financial personnel guarantee the truthfulness, accuracy, and completeness of this quarterly report and assume legal responsibility - The company's Board of Directors and management commit to the truthfulness, accuracy, and completeness of the quarterly report content and assume legal responsibility[2](index=2&type=chunk)[3](index=3&type=chunk) [Financial Statement Audit Status](index=1&type=section&id=Financial%20Statement%20Audit%20Status) The financial statements for this quarter are unaudited - The third-quarter financial statements are unaudited[3](index=3&type=chunk) I. Major Financial Data This section presents key financial data and indicators for the current quarter and year-to-date, highlighting revenue growth and changes in profitability and cash flow [Major Accounting Data and Financial Indicators](index=1&type=section&id=Major%20Accounting%20Data%20and%20Financial%20Indicators) Runben Co., Ltd.'s key financial data for Q3 2025 and year-to-date shows continued revenue growth, a slight year-over-year decrease in net profit attributable to shareholders for Q3, and a modest increase year-to-date, alongside significant growth in net operating cash flow, total assets, and owner's equity Key Accounting Data and Financial Indicators for Q3 2025 and Year-to-Date | Item | Current Period (2025 Q3) (CNY) | YoY Change (%) | Year-to-Date (2025 YTD) (CNY) | YoY Change (%) | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue | 342,414,289.33 | 16.67 | 1,237,521,845.97 | 19.28 | | Total Profit | 93,417,226.48 | -0.16 | 313,563,619.92 | 3.30 | | Net Profit Attributable to Shareholders | 78,522,780.07 | -2.89 | 266,047,503.56 | 1.98 | | Net Profit Attributable to Shareholders (Excluding Non-Recurring Items) | 74,268,718.88 | -7.58 | 251,228,377.22 | -1.79 | | Net Cash Flow from Operating Activities | 86,714,040.40 | 123.71 | 220,109,889.62 | 22.54 | | Basic Earnings Per Share (CNY/share) | 0.19 | -5.00 | 0.66 | 3.13 | | Diluted Earnings Per Share (CNY/share) | 0.19 | -5.00 | 0.66 | 3.13 | | Weighted Average Return on Net Assets (%) | 3.55 | decreased by 0.35 percentage points | 12.25 | decreased by 0.66 percentage points | Key Balance Sheet Indicators as of Q3 2025 End | Item | As of Current Period End (2025 Q3) (CNY) | As of Prior Year End (2024 FY) (CNY) | Change (%) | | :--- | :--- | :--- | :--- | | Total Assets | 2,306,585,927.30 | 2,219,337,493.41 | 3.93 | | Owner's Equity Attributable to Shareholders | 2,172,526,081.11 | 2,080,453,702.55 | 4.43 | [Non-Recurring Gains and Losses Items and Amounts](index=2&type=section&id=Non-Recurring%20Gains%20and%20Losses%20Items%20and%20Amounts) During the reporting period, the company's non-recurring gains and losses primarily stemmed from fair value changes in financial assets, government subsidies, and disposal of non-current assets, collectively having a positive impact on net profit Non-Recurring Gains and Losses Items for Q3 2025 and Year-to-Date | Non-Recurring Gains and Losses Item | Current Period Amount (2025 Q3) (CNY) | Year-to-Date Amount (2025 YTD) (CNY) | | :--- | :--- | :--- | | Gains/Losses from Disposal of Non-Current Assets | - | 80,153.55 | | Government Subsidies Included in Current Profit/Loss | 720,340.74 | 2,178,609.27 | | Gains/Losses from Fair Value Changes and Disposal of Financial Assets and Liabilities | 4,310,292.50 | 15,548,348.99 | | Other Non-Operating Income and Expenses | -49,574.79 | -180,429.35 | | Other Gains/Losses Meeting the Definition of Non-Recurring Items | - | 132,124.78 | | Less: Income Tax Impact | 726,997.26 | 2,939,680.90 | | Total | 4,254,061.19 | 14,819,126.34 | [Changes and Reasons for Major Accounting Data and Financial Indicators](index=3&type=section&id=Changes%20and%20Reasons%20for%20Major%20Accounting%20Data%20and%20Financial%20Indicators) The company did not disclose the reasons for changes in major accounting data and financial indicators, stating "not applicable" in the report - The company did not provide specific explanations for changes in major accounting data and financial indicators[9](index=9&type=chunk) II. Shareholder Information This section details the total number of common shareholders and the shareholding structure of the top ten shareholders, including the controlling shareholder and actual controllers [Total Number of Common Shareholders and Top Ten Shareholders' Holdings](index=3&type=section&id=Total%20Number%20of%20Common%20Shareholders%20and%20Top%20Ten%20Shareholders'%20Holdings) As of the end of the reporting period, the company had 26,173 common shareholders; Guangzhou Zhuofan Investment Holding Co., Ltd. is the controlling shareholder, with actual controllers Zhao Guiqin and Bao Songjuan and their affiliates collectively holding a majority of the company's shares, and several restricted share shareholders are present - As of the end of the reporting period, the total number of common shareholders was **26,173**, with no preferred shareholders whose voting rights have been restored[10](index=10&type=chunk) Top 10 Shareholders' Holdings as of Report Period End | Shareholder Name | Shareholder Nature | Number of Shares Held | Shareholding Ratio (%) | Number of Restricted Shares Held | Pledge, Mark, or Freeze Status | | :--- | :--- | :--- | :--- | :--- | :--- | | Guangzhou Zhuofan Investment Holding Co., Ltd. | Domestic Non-State-Owned Legal Person | 180,387,000 | 44.58 | 180,387,000 | None | | Zhao Guiqin | Domestic Natural Person | 72,522,000 | 17.92 | 72,522,000 | None | | Guangzhou Zhuofan Chengguang Investment Consulting Partnership (Limited Partnership) | Domestic Non-State-Owned Legal Person | 21,420,000 | 5.29 | 21,420,000 | None | | Bao Songjuan | Domestic Natural Person | 19,278,000 | 4.76 | 19,278,000 | None | | JNRY VIII HK Holdings Limited | Overseas Legal Person | 18,644,166 | 4.61 | 0 | None | | Guo Chao | Domestic Natural Person | 5,736,623 | 1.42 | 0 | None | | Zhao Hanqiu | Domestic Natural Person | 4,590,000 | 1.13 | 4,590,000 | None | | Bao Xinzuan | Domestic Natural Person | 3,062,200 | 0.76 | 3,062,200 | None | | Guangzhou Zhuofan Hesheng Investment Holding Partnership (Limited Partnership) | Domestic Non-State-Owned Legal Person | 2,458,300 | 0.61 | 0 | None | | China Life Insurance Co., Ltd. - Traditional - Ordinary Insurance Product - Shanghai 005L - CT001 | Other | 1,463,000 | 0.36 | 0 | None | - Actual controllers Zhao Guiqin and Bao Songjuan are a married couple, collectively controlling a majority of the company's shares through Guangzhou Zhuofan Investment Holding Co., Ltd., Guangzhou Zhuofan Chengguang Investment Consulting Partnership (Limited Partnership), and other affiliated parties[11](index=11&type=chunk) III. Other Reminders This section addresses any other significant information regarding the company's operating performance during the reporting period that investors should be aware of [Other Important Information for Investors Regarding Operating Performance](index=5&type=section&id=Other%20Important%20Information%20for%20Investors%20Regarding%20Operating%20Performance) The company did not disclose other important information regarding its operating performance during the reporting period that requires investor attention - The company has no other significant information requiring investor attention[12](index=12&type=chunk) IV. Quarterly Financial Statements This section presents the unaudited consolidated financial statements, including the balance sheet, income statement, and cash flow statement, for the reporting period [Type of Audit Opinion](index=5&type=section&id=Type%20of%20Audit%20Opinion) The financial statements for this quarter are unaudited - The financial statements for this quarter are unaudited[12](index=12&type=chunk) [Consolidated Balance Sheet](index=5&type=section&id=Consolidated%20Balance%20Sheet) As of September 30, 2025, the company's total assets increased by **3.93%** from the prior year-end, primarily driven by significant increases in other current assets and intangible assets, while financial assets held for trading decreased; total liabilities slightly declined, and owner's equity steadily grew Key Consolidated Balance Sheet Item Changes as of September 30, 2025 | Item | September 30, 2025 (CNY) | December 31, 2024 (CNY) | Change Amount (CNY) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | Cash and Cash Equivalents | 109,392,727.45 | 106,589,293.81 | 2,803,433.64 | 2.63 | | Financial Assets Held for Trading | 1,021,497,964.82 | 1,249,074,282.92 | -227,576,318.10 | -18.22 | | Accounts Receivable | 32,243,527.98 | 13,592,744.31 | 18,650,783.67 | 137.21 | | Prepayments | 19,012,284.36 | 11,490,859.76 | 7,521,424.60 | 65.46 | | Inventories | 134,997,615.32 | 118,573,128.58 | 16,424,486.74 | 13.85 | | Other Current Assets | 297,598,019.62 | 90,907,549.62 | 206,690,470.00 | 227.36 | | Total Current Assets | 1,620,157,432.44 | 1,594,831,016.45 | 25,326,415.99 | 1.59 | | Construction in Progress | 50,206,721.26 | 18,071,123.19 | 32,135,598.07 | 177.83 | | Intangible Assets | 87,845,373.26 | 54,538,027.37 | 33,307,345.89 | 61.07 | | Total Non-Current Assets | 686,428,494.86 | 624,506,476.96 | 61,922,017.90 | 9.92 | | Total Assets | 2,306,585,927.30 | 2,219,337,493.41 | 87,248,433.89 | 3.93 | | Accounts Payable | 84,798,947.34 | 61,137,957.35 | 23,660,989.99 | 38.70 | | Contract Liabilities | 2,957,374.81 | 13,365,914.39 | -10,408,539.58 | -77.87 | | Taxes Payable | 25,507,740.76 | 37,825,700.81 | -12,317,960.05 | -32.56 | | Total Current Liabilities | 129,514,452.71 | 137,189,098.79 | -7,674,646.08 | -5.59 | | Deferred Income | 3,959,516.27 | 8,672.57 | 3,950,843.70 | 45555.56 | | Total Non-Current Liabilities | 4,545,393.48 | 1,694,692.07 | 2,850,701.41 | 168.22 | | Total Liabilities | 134,059,846.19 | 138,883,790.86 | -4,823,944.67 | -3.47 | | Total Owner's Equity Attributable to Parent Company | 2,172,526,081.11 | 2,080,453,702.55 | 92,072,378.56 | 4.43 | [Consolidated Income Statement](index=8&type=section&id=Consolidated%20Income%20Statement) In the first three quarters of 2025, the company's total operating revenue increased by **19.28%** year-over-year, and net profit grew by **1.98%**, with a significant rise in sales expenses, a shift in financial expenses from negative to positive (reduced loss), and a substantial increase in investment income Key Consolidated Income Statement Item Changes for the First Three Quarters of 2025 | Item | First Three Quarters of 2025 (CNY) | First Three Quarters of 2024 (CNY) | Change Amount (CNY) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | Total Operating Revenue | 1,237,521,845.97 | 1,037,514,293.85 | 200,007,552.12 | 19.28 | | Total Operating Costs | 942,106,864.50 | 741,942,471.37 | 200,164,393.13 | 26.98 | | Operating Costs | 516,369,605.76 | 432,283,238.10 | 84,086,367.66 | 19.45 | | Selling Expenses | 370,383,121.28 | 282,898,111.64 | 87,485,009.64 | 30.93 | | Administrative Expenses | 24,465,307.88 | 21,449,066.60 | 3,016,241.28 | 14.06 | | R&D Expenses | 25,135,919.43 | 24,613,948.05 | 521,971.38 | 2.12 | | Financial Expenses | -6,533,683.11 | -30,735,902.67 | 24,202,219.56 | -78.74 | | Investment Income | 15,143,878.85 | 1,032,962.19 | 14,110,916.66 | 1366.12 | | Operating Profit | 313,737,358.02 | 298,569,624.18 | 15,167,733.84 | 5.08 | | Total Profit | 313,563,619.92 | 303,535,006.72 | 10,028,613.20 | 3.30 | | Net Profit | 266,047,503.56 | 260,884,103.81 | 5,163,399.75 | 1.98 | | Basic Earnings Per Share (CNY/share) | 0.66 | 0.64 | 0.02 | 3.13 | [Consolidated Cash Flow Statement](index=10&type=section&id=Consolidated%20Cash%20Flow%20Statement) In the first three quarters of 2025, net cash flow from operating activities significantly increased by **22.54%** year-over-year due to higher cash received from sales, while net cash outflow from investing activities substantially decreased, and net cash outflow from financing activities significantly increased, primarily for dividend distribution Key Consolidated Cash Flow Statement Item Changes for the First Three Quarters of 2025 | Item | First Three Quarters of 2025 (CNY) | First Three Quarters of 2024 (CNY) | Change Amount (CNY) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | Cash Received from Sales of Goods and Services | 1,364,507,388.86 | 1,155,002,846.47 | 209,504,542.39 | 18.14 | | Subtotal of Cash Inflows from Operating Activities | 1,373,473,547.02 | 1,164,130,381.55 | 209,343,165.47 | 17.98 | | Cash Paid for Goods and Services | 489,229,188.83 | 530,307,950.22 | -41,078,761.39 | -7.75 | | Cash Paid to and for Employees | 107,286,344.87 | 94,647,705.73 | 12,638,639.14 | 13.35 | | Taxes Paid | 150,552,081.10 | 136,464,958.72 | 14,087,122.38 | 10.32 | | Cash Paid for Other Operating Activities | 406,296,042.60 | 223,084,663.08 | 183,211,379.52 | 82.13 | | Subtotal of Cash Outflows from Operating Activities | 1,153,363,657.40 | 984,505,277.75 | 168,858,379.65 | 17.15 | | Net Cash Flow from Operating Activities | 220,109,889.62 | 179,625,103.80 | 40,484,785.82 | 22.54 | | Cash Received from Disposal of Investments | 1,776,585,834.55 | 631,487,037.81 | 1,145,098,796.74 | 181.33 | | Cash Received from Investment Income | 16,514,281.63 | 21,032,810.98 | -4,518,529.35 | -21.48 | | Cash Paid for Investments | 1,761,605,046.31 | 866,404,493.19 | 895,200,553.12 | 103.32 | | Net Cash Flow from Investing Activities | -42,162,777.55 | -259,172,089.84 | 217,009,312.29 | -83.73 | | Cash Paid for Dividends, Profit Distribution, or Interest Payments | 173,981,525.60 | 68,780,863.38 | 105,200,662.22 | 152.95 | | Net Cash Flow from Financing Activities | -175,120,824.80 | -74,871,162.58 | -100,249,662.22 | 133.89 | | Net Increase in Cash and Cash Equivalents | 2,803,433.64 | -154,418,460.86 | 157,221,894.50 | -101.82 | | Cash and Cash Equivalents at Period End | 109,392,727.45 | 129,406,720.91 | -20,013,993.46 | -15.47 |